Evidence map›Paper›PMID 26864103›Full record

ReviewImmunological reviews2016

Manipulation of the glycan-specific natural antibody repertoire for immunotherapy.

J Stewart New, R Glenn King, John F Kearney

Abstract readReview
In one paragraph

Review in Immunological reviews, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Glycan-Reactive Innate-like B Cells and Developmental Checkpoints.Journal of immunology (Baltimore, Md. : 1950) · 2024
    Article
  6. Article
  7. Open forum infectious diseases · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Low Levels of Natural Anti-α-Frontiers in microbiology · 2021
    Article
  13. N-glycosylated IgG in patients with kidney transplants increases calcium/calmodulin kinase IV in podocytes and causes injury.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Article
  14. Article
  15. Review
  16. Article
  17. The first, holistic immunological model of COVID-19: Implications for prevention, diagnosis, and public health measures.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2020
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

J Stewart NewDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
R Glenn KingDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
John F KearneyDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
University of Alabama at Birmingham · US

Funding

IMMUNOLOGIC DISEASES AND BASIC IMMUNOLOGYT32AI007051 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Laurie Ellen Harrington · 1985 to 2026
$13.1M
Regulation of B cell Clonal Diversity and Its Role in DiseaseR01AI014782 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KEARNEY, JOHN FRANKLIN · 1985 to 2020
$7.1M
Effects of neonatal microbial exposure on anti-polysaccharide B cell developmentU01AI100005 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KEARNEY, JOHN FRANKLIN · 2017 to 2021
$1.9M
Effects of neonatal microbial exposure on anti-polysaccharide B cell developmentR01AI100005 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KEARNEY, JOHN FRANKLIN · 2012 to 2016
$1.8M
The Influence of Anti-N-Acetyl-D-Glucosamine B cells on Type One Diabetes in MiceR56AI084991 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KEARNEY, JOHN FRANKLIN · 2010 to 2010
$366k
REGULATION OF B CELL CLONAL DIVERSITYR21AI014782 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KEARNEY, JOHN FRANKLIN · 2000 to 2000
$179k
Commensal-dependent maturation of the natural IgM repertoireF31AI120500 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI NEW, JAMES STEWART · 2015 to 2017
$80k
NIAID NIH HHS AI100005-03NIAID NIH HHS AI14782-37NIAID NIH HHS F31 AI120500NIAID NIH HHS F31AI120500NIAID NIH HHS R01 AI014782NIAID NIH HHS R01 AI100005NIAID NIH HHS R21 AI014782NIAID NIH HHS R56 AI084991NIAID NIH HHS T32 AI007051NIAID NIH HHS U01 AI100005
6 · The paper itself

Abstract

Natural immunoglobulin derived from innate-like B lymphocytes plays important roles in the suppression of inflammatory responses and represents a promising therapeutic target in a growing number of allergic and autoimmune diseases. These antibodies are commonly autoreactive and incorporate evolutionarily conserved specificities, including certain glycan-specific antibodies. Despite this conservation, exposure to bacterial polysaccharides during innate-like B lymphocyte development, through either natural exposure or immunization, induces significant changes in clonal representation within the glycan-reactive B cell pool. Glycan-reactive natural antibodies (NAbs) have been reported to play protective and pathogenic roles in autoimmune and inflammatory diseases. An understanding of the composition and functions of a healthy glycan-reactive NAb repertoire is therefore paramount. A more thorough understanding of NAb repertoire development holds promise for the design of both biological diagnostics and therapies. In this article, we review the development and functions of NAbs and examine three glycan specificities, represented in the innate-like B cell pool, to illustrate the complex roles environmental antigens play in NAb repertoire development. We also discuss the implications of increased clonal plasticity of the innate-like B cell repertoire during neonatal and perinatal periods, and the prospect of targeting B cell development with interventional therapies and correct defects in this important arm of the adaptive immune system.

Indexed as

ImmunotherapyAnimalsAntibodiesAntibody FormationAntibody SpecificityAntigensB-Lymphocyte SubsetsCell DifferentiationClonal Selection, Antigen-MediatedEpitopesGene Rearrangement, B-LymphocyteHumansImmunity, InnateMicrobiotaPolysaccharidesSymbiosisAntibodiesAntigensEpitopesPolysaccharidesB-1 B cellclonotypeglycan neodeterminantinnate-like B lymphocytenatural antibodyrepertoire development

Identifiers

PMID26864103
PMCPMC4755354
OpenAlexW2264497599

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.